Achilles Tendon RuptureNCT02531750
Metabolic Complications Following Achilles Tendon Rupture - A Cohort Study
An observational study of Achilles Tendon Rupture and Immobilization, run by Hvidovre University Hospital at 1 site in Denmark.
Trial summary
Introduction This study will evaluate the effect on glucose, lipid and bone metabolism following conservative orthopaedic procedures in patients who suffered from acute Achilles tendon rupture. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Achilles Tendon Rupture, Immobilization
- What is being tested?
- Immobilization due to an Achilles tendon rupture
- How many people
- 14 participants
- Where
- 1 siteDenmark
- Study dates
- Jun 2015to Apr 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Fifty non-diabetic individuals of age 18 to 70 years who should undergo non-operative treatment of acute Achilles tendon rupture and who are included to the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 at the department of orthopaedics, Hvidovre Hospital are recruited as cases for this study.
Who may be able to join
- Individuals of age 18 to 70 years
- Rupture of Achilles tendon happened within 5 days.
- The patient must be expected to be able to attend rehabilitation and post-examinations.
- The patient must be able to speak and understand Danish.
- The patient must be able to give informed consent.
Who cannot join
- Former rupture of one or both Achilles tendon(s)
- Previous surgery on the Achilles tendon
- Fluoroquinolone treatment within the last 6 months
- Tendinosis treated with corticosteroids (tablets or injections) within the last 6 months.
- The patient has been diagnosed with arterial insufficiency in the legs.
- Terminal illness or severe medical illness: ASA score higher than or equal to 3.
Show all 14Show fewer
- The space between the rupture and the calcaneus is less than 1cm.
- BMI >/= 35 kg/m2
- Known diabetes mellitus or HbA1c >/= 48 mol/mol
- Clinical significant anaemia, liver or kidney disease as judged by the sponsor or principal investigator.
- Thyroid function abnormality (TSH < 0.1 or TSH > 10)
- Calcium metabolic derangement, Ca++ < 1.1 or Ca++ > 1.40
- Known osteoporosis
- Re-rupture of the Achilles tendon between week 8 and 52
Trial locations and contacts
1 site in 1 country.
About this study
Introduction This study will evaluate the effect on glucose, lipid and bone metabolism following conservative orthopaedic procedures in patients who suffered from acute Achilles tendon rupture. The sedentary rehabilitation period following these procedures may impact negatively upon glucose, lipid and bone metabolic pathways whereas the more physically active rehabilitation period instituted 8 weeks after the injury is hypothesized to impose positive metabolic effects.
The study is addition to the on-going clinical trial, Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364.
Read more
Perspective This study will establish whether the well-known effects on glucose, lipid and bone metabolism of a sedentary lifestyle can be observed already following 8 weeks of almost total abstain from physical activity in non-diabetic individuals, who suffered an acute Achilles tendon rupture. Thereby, we will add knowledge to the previous findings following strict bed-rest in healthy individuals on glucose and lipid metabolism and bone turnover. In a clinical perspective it is important to examine the extent to which individuals deteriorate in various metabolic pathways to better understand the pathophysiology behind these defects both in healthy individuals and in patients, who undergo bed rest or an equal reduction in physical activity as part of their rehabilitation.
Study design The present study includes 50 cases, who are examined early following injury (< 2 weeks) (baseline), 8 weeks (6 - 10 weeks) after injury and 52 weeks (40 - 64 weeks) after injury, respectively.
Oral glucose tolerance test (OGTT) with ingestion of 75 g of glucose during a maximum of 3 min from baseline (0 min). Plasma for glucose, insulin, C-peptide, NEFA will be drawn.
The individual will bring in morning spot urine for measurement of suPAR, creatinine, albumin and orosomucoid.
The individual will have drawn blood for measurement of HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, Na, K, creatinine, HgB, CRP, leukocytes, ALAT, alkaline phosphatase, Ca++, D vitamin, TSH, albumine and amylase. Also blood for BTM and plasma suPAR, IL6, TNFa and hsCRP will be drawn. Finally blood for lipid density profiling and lipid particle size will be drawn DXA of hip and lumbar spine including abdominal visceral and subcutaneous fat is done on a Hologic Discovery scanner.
Read the detailed description
Introduction This study will evaluate the effect on glucose, lipid and bone metabolism following conservative orthopaedic procedures in patients who suffered from acute Achilles tendon rupture. The sedentary rehabilitation period following these procedures may impact negatively upon glucose, lipid and bone metabolic pathways whereas the more physically active rehabilitation period instituted 8 weeks after the injury is hypothesized to impose positive metabolic effects.
An on-going clinical trial, Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 is already addressing as primary endpoints the Achilles tendon total rupture score and patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture. The present study is an amendment/extension of that ongoing clinical trial.
An oral glucose tolerance test (OGTT) with frequent measurements of glucose, insulin, C-peptide and plasma free fatty acids can provide detailed information on insulin sensitivity, glucose tolerance, beta cell function, lipolysis and lipid oxidation as well as metabolic clearance of insulin(11-13).
Modern DXA scanners exhibit high performance and sensitivity to distinguish small changes in BMD. Also sensitive markers of changes in bone metabolism have recently been available. In particular two bone mass turnover markers (BTM) have been suggested to monitor bone resorption (CTX, carboxy-terminal cross-linked telopeptides of type 1 collagen) and bone formation ( P1NP, procollagen type 1 amino-terminal propeptide(14), but also osteocalcin (OC) is suggested as a marker of bone formation. DXA scanners have recently been validated to measure visceral adiposity, which is strongly associated with insulin sensitivity(15). A DXA scan exposes the individual to an X-ray radiation equal to only one day of background radiation, which makes this scanning modality much less harmful in terms of radiation dose compared to traditional CT scans (a 100-fold less radiation).
Traditional markers of low grade inflammation (LGI) include TNFa and IL6 and hsCRP. New promising markers include suPAR in plasma and urine and urine orosomucoid. suPAR has shown to predict CVD in non-diabetic community resting individuals(16). Urine orosomucoid is a strong predictor of major events in T2D and might be an early marker of glucose metabolic derangement(17). Low density lipoprotein (LDL) particles and especially those with a low particle size are atherogenic(18). Thus increased levels of LGI markers and immune markers including small LDL particles exhibit a particular at herogenic cocktail. A sedentary lifestyle is associated with an increase in these markers of LGI, impaired immune response and dyslipidaemia.
In the present setting we want to investigate the putative negative impact on glucose, lipid, and bone metabolism during a period of restrain from exercise secondary to immobilization following Achilles tendon rupture. We also want to study these patients during their physical active rehabilitation (at week 8 - 52), to establish whether they succeed in improving the metabolic impairments they suffered during the early post-injury period, during which period strong limitations in physical activity is prescribed (week 0 - 8).
Perspective This study will establish whether the well-known effects on glucose, lipid and bone metabolism of a sedentary lifestyle can be observed already following 8 weeks of almost total abstain from physical activity in non-diabetic individuals, who suffered an acute Achilles tendon rupture. Thereby, we will add knowledge to the previous findings following strict bed-rest in healthy individuals on glucose and lipid metabolism and bone turnover. In a clinical perspective it is important to examine the extent to which individuals deteriorate in various metabolic pathways to better understand the pathophysiology behind these defects both in healthy individuals and in patients, who undergo bed rest or an equal reduction in physical activity as part of their rehabilitation.
Hypothesis Implementation of a sedentary lifestyle with almost no physical activity in non-diabetic individuals undergoing non-operative treatment of acute Achilles tendon rupture will during 8 weeks
- impair insulin sensitivity and glucose effectiveness
- decrease disposition index
- compensatory decrease in insulin clearance
- decrease lipid oxidation
- increase visceral adipose tissue
- increase number of low density lipoprotein particles and a decrease the particle size
- increase immune and low grade inflammatory response as measured in plasma and urine
- induce bone loss in hip as measured by BMD
- increase bone resorption and decrease bone formation as measured by selected bone turnover markers.
During the following physical active rehabilitation from week 8 to week 52 the above proposed negative impact upon glucose, lipid and bone metabolism is thought to reverse at least partly so.
The relative positive effect on metabolic performance is hypothesized to be associated with duration from immobilization to full mobilization, which will be monitored by use of validated tools.
Study design Fifty non-diabetic individuals of age 18 to 70 years who should undergo non-operative treatment of acute Achilles tendon rupture and who are included to the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 at the department of orthopaedics, Hvidovre Hospital are recruited as cases for this study. That study examines the effect on functional outcome measures of early controlled mobilization of the ankle from the beginning of week 3 following injury versus full immobilization during the initial 8 weeks post injury. Both groups are allowed full weight-bearing from the beginning of week 3 and physical activity level is expected to be the same in the two groups. As such randomization regime is unlikely to influence metabolism.
The present study includes 50 cases, who are examined early following injury (< 2 weeks) (baseline), 8 weeks (6 - 10 weeks) after injury and 52 weeks (40 - 64 weeks) after injury, respectively.
Examinations Oral glucose tolerance test (OGTT) with ingestion of 75 g of glucose during a maximum of 3 min from baseline (0 min). Plasma for glucose, insulin, C-peptide, NEFA will be drawn at time -10, -5, -1, 10, 15, 20, 30, 45, 60, 75, 90, 105, 120, 150, 180, 240 min. This test will be performed in the morning starting at approximately 8 am. The tests are done after an overnight fast of at least 10 hours.
The individual will bring in morning spot urine for measurement of suPAR, creatinine, albumin and orosomucoid.
Before the OGTT the individual will have drawn blood for measurement of HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, Na, K, creatinine, HgB, CRP, leukocytes, ALAT, alkaline phosphatase, Ca++, D vitamin, TSH, albumine and amylase. Also blood for BTM and plasma suPAR, IL6, TNFa and hsCRP will be drawn. Finally blood for lipid density profiling and lipid particle size will be drawn before the OGTT.
Body weight and height and waist and hip circumference will be measured. DXA of hip and lumbar columna including abdominal visceral and subcutaneous fat is done on a Hologic Discovery scanner by use of updated software. DXA will be carried out approximately at 12 am.
Acquisition of glucose and lipid metabolism will be done by use of the MinModel and the NEFA MinModel as described (11;12) All blood and urine samples will be destroyed after analysis. However a research biobank will be established since the period of time from most blood and urine sampling until analysis exceeds 1 week. This study will store all urine and blood samples in a freezer until all case subjects and controls have finished examinations. The duration of this period will be maximum 2 years from last patient last visit. Thus the research biobank will be established for storage only.
The urine and blood samples will be destroyed after analysis at Hvidovre and Glostrup Hospitals. Analysis results will all be anonymous and some will be sent abroad to our researcher Prof. Raymond Boston in USA, who will perform statistical calculations from analysis data. Permission for establishment of a research biobank is obtained from the Danish Data protection Agency.
Measurements of physical activity are acquired from the Primary Investigators ongoing trial "Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization".
Statistics Ten days of bed rest in 13 healthy young individuals showed a 20% (P<0.05) significant decrease in insulin sensitivity and a 50% (P<0.05) reduction in lipid oxidation(2). Thirty-one days of bed rest in 8 healthy women was significantly associated with bone loss in total hip (2.07%, P<0.001)(7).
The present study does not imply strict bed rest but exhibits a longer sedentary period of following up compared to the above studies and include a larger number of participants, also. During the initial 8 weeks of strictly sedentary immobilization following the injury of the Achilles tendon we suggest that the patients will decrease their insulin sensitivity by at least 20%, the estimate of SD of the endpoint is 20%. Thus, using the MIREDIF statistics (Douglas Altman, Practical statistics for Medical research, Chapman \& Hall, 1999), we can calculate that a population of 22 patients will generate a power >90% at significance level P<0.05 to investigate that primary endpoint. Similarly, the SD on lipidoxidation is 30% and the estimate is that the change during the sedentary period is at least 30%, thus by n=22 patients the power will be > 90%. Finally the change in BMD is likely 1% and the SD is 1%, thus n=22 patients will provide a statistical power of at least 90%. During the period of physical restitution we estimate a fully reversion of the deficit in endpoints during the sedentary period, i.e. similar calculation on power is valid during the restitution period.
The participants in the present study are included from the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared with Immobilization. Randomization regime is unlikely to influence metabolism, however, it will be considered as a variable in the statistical analyses of the endpoints.
Ethical issues The study adheres to the Danish Act on Processing of Personal Data and, Danish Act on Health and the Helsinki II convention of clinical trials. All participants are informed about the purpose of the study and all ethical issues and a written consent is obtained before participation. At any given time, the participants can withdraw their acceptant for participation in the study. Personal data concerning demographic relations such as gender and age will be accessed as well to ensure the case subjects meet the inclusion criteria and for statistically use. To make assessments on study participation, the principal investigator will also gain access to relevant data from the patients medical files concerning illnesses or conditions the case subject might report.
The amount of blood drawn during the 52 weeks of participation in the study is less than 500 ml, which is the standard amount of blood drawn at a single donation of blood from a blood donor. The use of intravenous cannula can cause irritation or infection of vein or insertion site. All procedures will be performed as described in SOP.
The X-ray radiation from DXA during the study period equals 3 days of background radiation in Denmark and this amount of radiation is 30-fold less than that of a standard CT-scan of abdomen. In other words the dose of radiation is so low that a calculation of risk is not possible.
- Conditions
- Achilles Tendon Rupture, Immobilization
- Being tested
- Immobilization due to an Achilles tendon rupture
- Keywords
- Metabolism, Bone metabolism, Glucose Metabolism, Lipid metabolism, Low grade inflamation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Immobilization due to an Achilles tendon ruptureOther
| Study group | Role | What they receive |
|---|---|---|
| Achilles tendon rupture | Patients with acute Achilles tendon rupture. Receives: Other: Immobilization due to an Achilles tendon rupture |
What is being measured
The primary outcome is the main question the study is designed to answer.
Glucose metabolism
Insulin sensitivity as measured by MinModel-OGTT
Measured: Metabolic derangement: 0 to 8 weeks
Lipid metabolism
Lipid oxidation as measured by MinModel-NEFA
Measured: Metabolic derangement: 0 to 8 weeks
Bone metabolism
BMD changes in total hip
Measured: Metabolic derangement: 0 to 8 weeks
Atherosclerotic markers
Changes in low density lipoprotein particles and in particle size
Measured: Metabolic derangement: 0 to 8 weeks
Secondary outcomes (11)
Glucose metabolism
beta-cell responsiveness compared to insulin sensitivity (disposition index)
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
glucose effectiveness
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
insulin clearance
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
changes in visceral adipose tissue
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Lipid metabolism
changes in lipolysis
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Lipid metabolism
changes in rates of which NEFA leaves plasma pool
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
changes in total BMD
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
changes in lumbar BMD
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
changes in BTM of bone resorption (CTX) and formation (P1NP, OC)
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Atherosclerotic markers: Lipoproteins, immune response and low grade inflammation
changes in TNFa, IL6, hsCRP, suPAR and orosomucoid
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Atherosclerotic markers: Lipoproteins, immune response and low grade inflammation
changes in density profiling of LDL and HDL cholesterol
Measured: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2015 (estimated)
- Study startJun 2015
- Primary completionApr 2017
- Study completionApr 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Achilles Tendon RuptureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 14 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hvidovre University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kristoffer Barfod, Hvidovre University Hospital
- Investigators
- Kristoffer W Barfod, MD, Principal investigator, Hvidovre University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02531750
- Sponsor's protocol ID
- ATR_ORTHOMED
- Status last verified
- Aug 2017
- First submitted
- 6 Mar 2015
- Last updated
- 9 Aug 2017
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 9 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Metabolic Complications Following Achilles Tendon Rupture - A Cohort Study
- ClinicalTrials.gov ID
- NCT02531750
- Acronym / sponsor ID
- ATR_ORTHOMED
- Conditions
- Achilles Tendon Rupture, Immobilization
- Keywords
- Metabolism, Bone metabolism, Glucose Metabolism, Lipid metabolism, Low grade inflamation
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 14 participants (actual)
- Lead sponsor
- Hvidovre University HospitalUniversity, hospital or other
- Study start
- Jun 2015
- Primary completion
- Apr 2017 (actual)
- Study completion
- Apr 2017 (actual)
- First posted
- 24 Aug 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Introduction This study will evaluate the effect on glucose, lipid and bone metabolism following conservative orthopaedic procedures in patients who suffered from acute Achilles tendon rupture. The sedentary rehabilitation period following these procedures may impact negatively upon glucose, lipid and bone metabolic pathways whereas the more physically active rehabilitation period instituted 8 weeks after the injury is hypothesized to impose positive metabolic effects.
The study is addition to the on-going clinical trial, Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364.
Perspective This study will establish whether the well-known effects on glucose, lipid and bone metabolism of a sedentary lifestyle can be observed already following 8 weeks of almost total abstain from physical activity in non-diabetic individuals, who suffered an acute Achilles tendon rupture. Thereby, we will add knowledge to the previous findings following strict bed-rest in healthy individuals on glucose and lipid metabolism and bone turnover. In a clinical perspective it is important to examine the extent to which individuals deteriorate in various metabolic pathways to better understand the pathophysiology behind these defects both in healthy individuals and in patients, who undergo bed rest or an equal reduction in physical activity as part of their rehabilitation.
Study design The present study includes 50 cases, who are examined early following injury (< 2 weeks) (baseline), 8 weeks (6 - 10 weeks) after injury and 52 weeks (40 - 64 weeks) after injury, respectively.
Oral glucose tolerance test (OGTT) with ingestion of 75 g of glucose during a maximum of 3 min from baseline (0 min). Plasma for glucose, insulin, C-peptide, NEFA will be drawn.
The individual will bring in morning spot urine for measurement of suPAR, creatinine, albumin and orosomucoid.
The individual will have drawn blood for measurement of HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, Na, K, creatinine, HgB, CRP, leukocytes, ALAT, alkaline phosphatase, Ca++, D vitamin, TSH, albumine and amylase. Also blood for BTM and plasma suPAR, IL6, TNFa and hsCRP will be drawn. Finally blood for lipid density profiling and lipid particle size will be drawn DXA of hip and lumbar spine including abdominal visceral and subcutaneous fat is done on a Hologic Discovery scanner.
Detailed description
Introduction This study will evaluate the effect on glucose, lipid and bone metabolism following conservative orthopaedic procedures in patients who suffered from acute Achilles tendon rupture. The sedentary rehabilitation period following these procedures may impact negatively upon glucose, lipid and bone metabolic pathways whereas the more physically active rehabilitation period instituted 8 weeks after the injury is hypothesized to impose positive metabolic effects.
An on-going clinical trial, Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 is already addressing as primary endpoints the Achilles tendon total rupture score and patient reported validation score developed to assess symptoms and physical activity after treatment for Achilles tendon rupture. The present study is an amendment/extension of that ongoing clinical trial.
An oral glucose tolerance test (OGTT) with frequent measurements of glucose, insulin, C-peptide and plasma free fatty acids can provide detailed information on insulin sensitivity, glucose tolerance, beta cell function, lipolysis and lipid oxidation as well as metabolic clearance of insulin(11-13).
Modern DXA scanners exhibit high performance and sensitivity to distinguish small changes in BMD. Also sensitive markers of changes in bone metabolism have recently been available. In particular two bone mass turnover markers (BTM) have been suggested to monitor bone resorption (CTX, carboxy-terminal cross-linked telopeptides of type 1 collagen) and bone formation ( P1NP, procollagen type 1 amino-terminal propeptide(14), but also osteocalcin (OC) is suggested as a marker of bone formation. DXA scanners have recently been validated to measure visceral adiposity, which is strongly associated with insulin sensitivity(15). A DXA scan exposes the individual to an X-ray radiation equal to only one day of background radiation, which makes this scanning modality much less harmful in terms of radiation dose compared to traditional CT scans (a 100-fold less radiation).
Traditional markers of low grade inflammation (LGI) include TNFa and IL6 and hsCRP. New promising markers include suPAR in plasma and urine and urine orosomucoid. suPAR has shown to predict CVD in non-diabetic community resting individuals(16). Urine orosomucoid is a strong predictor of major events in T2D and might be an early marker of glucose metabolic derangement(17). Low density lipoprotein (LDL) particles and especially those with a low particle size are atherogenic(18). Thus increased levels of LGI markers and immune markers including small LDL particles exhibit a particular at herogenic cocktail. A sedentary lifestyle is associated with an increase in these markers of LGI, impaired immune response and dyslipidaemia.
In the present setting we want to investigate the putative negative impact on glucose, lipid, and bone metabolism during a period of restrain from exercise secondary to immobilization following Achilles tendon rupture. We also want to study these patients during their physical active rehabilitation (at week 8 - 52), to establish whether they succeed in improving the metabolic impairments they suffered during the early post-injury period, during which period strong limitations in physical activity is prescribed (week 0 - 8).
Perspective This study will establish whether the well-known effects on glucose, lipid and bone metabolism of a sedentary lifestyle can be observed already following 8 weeks of almost total abstain from physical activity in non-diabetic individuals, who suffered an acute Achilles tendon rupture. Thereby, we will add knowledge to the previous findings following strict bed-rest in healthy individuals on glucose and lipid metabolism and bone turnover. In a clinical perspective it is important to examine the extent to which individuals deteriorate in various metabolic pathways to better understand the pathophysiology behind these defects both in healthy individuals and in patients, who undergo bed rest or an equal reduction in physical activity as part of their rehabilitation.
Hypothesis Implementation of a sedentary lifestyle with almost no physical activity in non-diabetic individuals undergoing non-operative treatment of acute Achilles tendon rupture will during 8 weeks
- impair insulin sensitivity and glucose effectiveness
- decrease disposition index
- compensatory decrease in insulin clearance
- decrease lipid oxidation
- increase visceral adipose tissue
- increase number of low density lipoprotein particles and a decrease the particle size
- increase immune and low grade inflammatory response as measured in plasma and urine
- induce bone loss in hip as measured by BMD
- increase bone resorption and decrease bone formation as measured by selected bone turnover markers.
During the following physical active rehabilitation from week 8 to week 52 the above proposed negative impact upon glucose, lipid and bone metabolism is thought to reverse at least partly so.
The relative positive effect on metabolic performance is hypothesized to be associated with duration from immobilization to full mobilization, which will be monitored by use of validated tools.
Study design Fifty non-diabetic individuals of age 18 to 70 years who should undergo non-operative treatment of acute Achilles tendon rupture and who are included to the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 at the department of orthopaedics, Hvidovre Hospital are recruited as cases for this study. That study examines the effect on functional outcome measures of early controlled mobilization of the ankle from the beginning of week 3 following injury versus full immobilization during the initial 8 weeks post injury. Both groups are allowed full weight-bearing from the beginning of week 3 and physical activity level is expected to be the same in the two groups. As such randomization regime is unlikely to influence metabolism.
The present study includes 50 cases, who are examined early following injury (< 2 weeks) (baseline), 8 weeks (6 - 10 weeks) after injury and 52 weeks (40 - 64 weeks) after injury, respectively.
Examinations Oral glucose tolerance test (OGTT) with ingestion of 75 g of glucose during a maximum of 3 min from baseline (0 min). Plasma for glucose, insulin, C-peptide, NEFA will be drawn at time -10, -5, -1, 10, 15, 20, 30, 45, 60, 75, 90, 105, 120, 150, 180, 240 min. This test will be performed in the morning starting at approximately 8 am. The tests are done after an overnight fast of at least 10 hours.
The individual will bring in morning spot urine for measurement of suPAR, creatinine, albumin and orosomucoid.
Before the OGTT the individual will have drawn blood for measurement of HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride, Na, K, creatinine, HgB, CRP, leukocytes, ALAT, alkaline phosphatase, Ca++, D vitamin, TSH, albumine and amylase. Also blood for BTM and plasma suPAR, IL6, TNFa and hsCRP will be drawn. Finally blood for lipid density profiling and lipid particle size will be drawn before the OGTT.
Body weight and height and waist and hip circumference will be measured. DXA of hip and lumbar columna including abdominal visceral and subcutaneous fat is done on a Hologic Discovery scanner by use of updated software. DXA will be carried out approximately at 12 am.
Acquisition of glucose and lipid metabolism will be done by use of the MinModel and the NEFA MinModel as described (11;12) All blood and urine samples will be destroyed after analysis. However a research biobank will be established since the period of time from most blood and urine sampling until analysis exceeds 1 week. This study will store all urine and blood samples in a freezer until all case subjects and controls have finished examinations. The duration of this period will be maximum 2 years from last patient last visit. Thus the research biobank will be established for storage only.
The urine and blood samples will be destroyed after analysis at Hvidovre and Glostrup Hospitals. Analysis results will all be anonymous and some will be sent abroad to our researcher Prof. Raymond Boston in USA, who will perform statistical calculations from analysis data. Permission for establishment of a research biobank is obtained from the Danish Data protection Agency.
Measurements of physical activity are acquired from the Primary Investigators ongoing trial "Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization".
Statistics Ten days of bed rest in 13 healthy young individuals showed a 20% (P<0.05) significant decrease in insulin sensitivity and a 50% (P<0.05) reduction in lipid oxidation(2). Thirty-one days of bed rest in 8 healthy women was significantly associated with bone loss in total hip (2.07%, P<0.001)(7).
The present study does not imply strict bed rest but exhibits a longer sedentary period of following up compared to the above studies and include a larger number of participants, also. During the initial 8 weeks of strictly sedentary immobilization following the injury of the Achilles tendon we suggest that the patients will decrease their insulin sensitivity by at least 20%, the estimate of SD of the endpoint is 20%. Thus, using the MIREDIF statistics (Douglas Altman, Practical statistics for Medical research, Chapman \& Hall, 1999), we can calculate that a population of 22 patients will generate a power >90% at significance level P<0.05 to investigate that primary endpoint. Similarly, the SD on lipidoxidation is 30% and the estimate is that the change during the sedentary period is at least 30%, thus by n=22 patients the power will be > 90%. Finally the change in BMD is likely 1% and the SD is 1%, thus n=22 patients will provide a statistical power of at least 90%. During the period of physical restitution we estimate a fully reversion of the deficit in endpoints during the sedentary period, i.e. similar calculation on power is valid during the restitution period.
The participants in the present study are included from the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared with Immobilization. Randomization regime is unlikely to influence metabolism, however, it will be considered as a variable in the statistical analyses of the endpoints.
Ethical issues The study adheres to the Danish Act on Processing of Personal Data and, Danish Act on Health and the Helsinki II convention of clinical trials. All participants are informed about the purpose of the study and all ethical issues and a written consent is obtained before participation. At any given time, the participants can withdraw their acceptant for participation in the study. Personal data concerning demographic relations such as gender and age will be accessed as well to ensure the case subjects meet the inclusion criteria and for statistically use. To make assessments on study participation, the principal investigator will also gain access to relevant data from the patients medical files concerning illnesses or conditions the case subject might report.
The amount of blood drawn during the 52 weeks of participation in the study is less than 500 ml, which is the standard amount of blood drawn at a single donation of blood from a blood donor. The use of intravenous cannula can cause irritation or infection of vein or insertion site. All procedures will be performed as described in SOP.
The X-ray radiation from DXA during the study period equals 3 days of background radiation in Denmark and this amount of radiation is 30-fold less than that of a standard CT-scan of abdomen. In other words the dose of radiation is so low that a calculation of risk is not possible.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Achilles tendon rupture | – | Other: Immobilization due to an Achilles tendon rupturePatients with acute Achilles tendon rupture. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Fifty non-diabetic individuals of age 18 to 70 years who should undergo non-operative treatment of acute Achilles tendon rupture and who are included to the randomized clinical trial: Non-operative Treatment of Acute Achilles Tendon Rupture: Early Controlled Mobilization Compared With Immobilization, ClinicalTrials.gov Identifier: NCT02015364 at the department of orthopaedics, Hvidovre Hospital are recruited as cases for this study.
Key inclusion criteria (5 listed)
- Individuals of age 18 to 70 years
- Rupture of Achilles tendon happened within 5 days.
- The patient must be expected to be able to attend rehabilitation and post-examinations.
- The patient must be able to speak and understand Danish.
- The patient must be able to give informed consent.
Key exclusion criteria (14 listed)
- Former rupture of one or both Achilles tendon(s)
- Previous surgery on the Achilles tendon
- Fluoroquinolone treatment within the last 6 months
- Tendinosis treated with corticosteroids (tablets or injections) within the last 6 months.
- The patient has been diagnosed with arterial insufficiency in the legs.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Immobilization due to an Achilles tendon rupture | Other | Achilles tendon rupture |
Primary outcome
Glucose metabolism
Time frame: Metabolic derangement: 0 to 8 weeks
Insulin sensitivity as measured by MinModel-OGTT
Lipid metabolism
Time frame: Metabolic derangement: 0 to 8 weeks
Lipid oxidation as measured by MinModel-NEFA
Bone metabolism
Time frame: Metabolic derangement: 0 to 8 weeks
BMD changes in total hip
Atherosclerotic markers
Time frame: Metabolic derangement: 0 to 8 weeks
Changes in low density lipoprotein particles and in particle size
11 secondary outcomes
Glucose metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Glucose metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Lipid metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Lipid metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Bone metabolism
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Atherosclerotic markers: Lipoproteins, immune response and low grade inflammation
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Atherosclerotic markers: Lipoproteins, immune response and low grade inflammation
Time frame: Metabolic derangement: 8 weeks; Metabolic restoration 52 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Aug 2017.
Related trials for Achilles Tendon Rupture
Not yet recruiting
Early Functional Outcomes After Open Versus Percutaneous Repair of Acute Achilles Tendon Ruptures
Patients With an Acute Achilles Tendon Rupture, Time From Achilles Tendon Rupture to Surgery of Less Than 2 Weeks
Recruiting
Blood Flow Restriction Exercise in Patients With an Achilles Tendon Rupture
Achilles Tendon Rupture
Enrolling by invitationObservational study
Achilles Non-SNIS REGENETEN
Complete Mid-portion Achilles Rupture
RecruitingObservational study
Achilles Tendon Rupture Patient Outcomes at 12 Months
Achilles Tendon Rupture
Recruiting
Effect of BFR Rehab After Achilles Tendon Rupture
Achilles Tendon Rupture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kristoffer W Barfod, MD principal investigator
Hvidovre University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Achilles Tendon Rupture and Immobilization, run by Hvidovre University Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Glucose metabolism (time frame: Metabolic derangement: 0 to 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Aug 2017.